SummaryIRF-3, a member of the interferon regulatory factor (IRF) family of transcription factors, functions in innate immune defense against viral infection. Upon infection, host cell IRF-3 is activated by phosphorylation at its 7 C-terminal Ser/Thr residues, 385 SSLENTVDLHISNSHPLSLTS 405 . This phosphoactivation triggers IRF-3 to react with the coactivators, CREB-binding protein (CBP)/p300, to form a complex that activates target genes in the nucleus. However, the role of each phosphorylation site for IRF-3 phosphoactivation remains unresolved. To address this issue, we screened all 7 Ser/Thr potential phosphorylation sites by mutational studies, size-exclusion chromatography, and isothermal titration calorimetry. Using purified proteins, we show that CBP (aa 2067-2112) interacts directly with IRF-3 (aa 173-427) and 6 of its single-site mutants to form heterodimers, but when CBP interacts with IRF-3 S396D, oligomerization is evident. CBP also interacts in vitro with IRF-3 double-site mutants to form different levels of oligomerization. Among all the single-site mutants, IRF-3 S396D showed the strongest binding to CBP. Although IRF-3 S386D alone did not interact as strongly with CBP as did other mutants, it strengthened the interaction and oligomerization of IRF-3 S396D with CBP. In contrast, IRF-3 S385D weakened the interaction and oligomerization of IRF-3 S396D and S386/396D with CBP. Thus, it appears that Ser 385 and Ser 386 serve antagonistic functions in regulating IRF-3 phosphoactivation. These results indicate that serines 386 and 396 are critical for IRF-3 activation and support a phosphorylationoligomerization model for IRF-3 activation.